Keywords: Biocon, Malaysia, Investment, R&D facility, Biomanufacturing

India’s Biocon spreads its wings, investing $161-million in Malaysian unit

Article | 28 October 2010

Print This

Bangalore, India-based biotech firm Biocon (BSE: 532523) is making a big foray into the Malaysian market, saying it will set up ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in